Diamyd spins out the subsidiary Diamyd Therapeutics which changes name to Diamyd Medical

At an Extraordinary General Meeting of Diamyd Medical AB on April 22, 2013, it was decided to distribute the subsidiary Diamyd Therapeutics AB with the diabetes operations to the shareholders. At the same time the company assumes the name Diamyd Medical AB. The new Diamyd Medical will keep the web address www.diamyd.com. The parent company (former Diamyd Medical) will change name to Mertiva AB and its web address to www.mertiva.se.The new Diamyd Medical is capitalized with approximately SEK 50 million to continue the work to find a cure for autoimmune diabetes, focusing on continued